Several studies have investigated that quantitative image features from preoperative imaging of gliomas can be used to predict IDH and alpha-thalassemia/mental retardation syndrome X-linked (ATRX) mutations, EGFR amplification, and MGMT promoter methylation [10–14]. Here, ATRX is linked to central nervous system cancer.